RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 96 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $566,000 | +528.9% | 220,164 | +461.4% | 0.12% | +875.0% |
Q4 2018 | $90,000 | +69.8% | 39,220 | +163.9% | 0.01% | +200.0% |
Q1 2018 | $53,000 | +55.9% | 14,861 | +38.8% | 0.00% | -66.7% |
Q2 2015 | $34,000 | +3.0% | 10,706 | -37.9% | 0.01% | -36.8% |
Q3 2014 | $33,000 | -89.4% | 17,239 | -84.2% | 0.02% | -84.7% |
Q4 2013 | $312,000 | – | 109,452 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |